Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001061983-21-000116)

Filing Details

Accession Number:: 0001061983-21-000116
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-04-23 17:32:58
Reporting Period:: 2021-04-23

Accepted Time:: 2021-04-23 17:32:58
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1061983	Cytokinetics Inc	CYTK	Pharmaceutical Preparations (2834)	943291317

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1243004	D Sandford Smith	280 East Grand Avenue South San Francisco CA 94080		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-04-23	5,000	$9.45	5,920	No	4	M	Direct
Common Stock	Disposition	2021-04-23	5,000	$26.50	920	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2021-04-23	5,000	$0.00	5,000	$9.45

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
10,000	2019-05-16	2028-05-16	No	4	M	Direct

Footnotes

Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 10, 2021.
Amount includes 920 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program.